- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Madrigal Pharmaceuticals
Market Cap: US$11.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$520.09
7D
-1.3%
1Y
57.0%
Insmed
Market Cap: US$29.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$135.98
7D
-3.5%
1Y
90.4%
Ionis Pharmaceuticals
Market Cap: US$12.1b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$72.23
7D
-3.5%
1Y
142.9%
Alnylam Pharmaceuticals
Market Cap: US$40.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$308.51
7D
-0.8%
1Y
21.1%
Ascendis Pharma
Market Cap: US$14.2b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$226.66
7D
-7.6%
1Y
n/a
Neurocrine Biosciences
Market Cap: US$12.8b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$128.04
7D
-2.7%
1Y
20.3%
BeOne Medicines
Market Cap: US$33.4b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$298.90
7D
-6.0%
1Y
19.8%
BridgeBio Pharma
Market Cap: US$14.4b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$74.52
7D
-2.2%
1Y
104.6%
AbbVie
Market Cap: US$351.5b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$197.38
7D
-3.1%
1Y
2.6%
Jazz Pharmaceuticals
Market Cap: US$12.4b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$201.22
7D
1.1%
1Y
72.9%
Eli Lilly
Market Cap: US$791.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$868.27
7D
-5.6%
1Y
-1.0%
Natera
Market Cap: US$29.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$204.39
7D
-0.5%
1Y
32.0%
Viatris
Market Cap: US$17.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$14.81
7D
-0.4%
1Y
79.5%
Royalty Pharma
Market Cap: US$29.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$49.65
7D
0.7%
1Y
52.6%
Elanco Animal Health
Market Cap: US$11.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.09
7D
-6.7%
1Y
132.3%
BioMarin Pharmaceutical
Market Cap: US$10.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$53.81
7D
-2.0%
1Y
-14.6%
Waters
Market Cap: US$30.4b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$299.79
7D
-10.7%
1Y
-11.8%